Additional information
| Therapeutic Segment | Immunostimulants in respiratory diseases |
|---|---|
| Dosage Form | Liquid |
| Specialities | Chest Physician, ENT, Physician |
Pidotimod induces dendritic cell (DC) maturation, upregulates the expression of HLA-DR and co-stimulatory molecules CD83 and CD86, stimulates DCs to release pro-inflammatory molecules, driving T cell proliferation and differentiation towards a Th1 phenotype, enhances natural killer cell functions, inhibits thymocyte ...
As directed by physician
